Currently out of the existing stock ratings of Ami Fadia, 218 are a BUY (87.2%), 26 are a HOLD (10.4%), 6 are a SELL (2.4%).

Ami Fadia

Work Performance Price Targets & Ratings Chart

Analyst Ami Fadia works at NEEDHAM with a stock forecast success ratio of 42.57% fulfilled within 175.33 days on average. Previously, Ami Fadia worked at LEERINK.

Ami Fadia’s has documented 480 price targets and ratings displayed on 31 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on RVMD, Revolution Medicines at 08-Apr-2024.

Wall Street Analyst Ami Fadia

Analyst best performing recommendations are on RVMD (REVOLUTION MEDICINES).
The best stock recommendation documented was for RVMD (REVOLUTION MEDICINES) at 10/12/2023. The price target of $34 was fulfilled within 4 days with a profit of $9.8 (40.5%) receiving and performance score of 101.24.

Average potential price target upside

AMRN Amarin PLC ARDX Ardelyx AVDL Avadel Pharmaceuticals PLC BIIB Biogen HRMY Harmony Biosciences Holdings HRTX Heron Therapeuti JAZZ Jazz Pharmaceuticals PLC MYOV Myovant Sciences Ltd OBSV ObsEva SA SAGE Sage Therapeutic BCYC Bicycle Therapeutics Ltd ITCI Intracellular Th MNK Mallinckrodt plc MRUS Merus BV NBIX Neurocrine Biosciences TEVA Teva Pharma Industries Ltd ADR ACAD ACADIA Pharmaceuticals AMRX Amneal Pharmaceuticals, . Common Stock MYL Viatris PCRX Pacira Pharmaceuticals SGEN Seagen VTRS Viatris DAWN Day One Biopharmaceuticals ASRT Assertio Therapeutics BPMC Blueprint Medicines Corp COGT Cogent Biosciences ENDP Endo International PLC PRGO Perrigo Company PLC RVMD Revolution Medicines THRX Theseus Pharmaceuticals IMRX Immuneering Corp

Analyst name


Current price target

Potential distance

Previous price target


Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score


4 months 24 days ago

1/3 (33.33%)

$-0.04 (-0.99%)




$-0.07 (-6.54%)


5 months 19 days ago

4/21 (19.05%)

$0.29 (40.85%)




$-0.07 (-6.54%)


8 months 25 days ago

8/11 (72.73%)

$-0.08 (-7.41%)




$0.18 (16.82%)


8 months 25 days ago

2/5 (40%)

$0.17 (15.74%)




1 years 9 months 22 days ago

13/47 (27.66%)

$6.81 (213.48%)


Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Ami Fadia is most bullish on?

Potential upside of $104.91 has been obtained for JAZZ (JAZZ PHARMACEUTICALS PLC)

Which stock is Ami Fadia is most reserved on?

Potential downside of $2.25 has been obtained for HRTX (HERON THERAPEUTI)

What Year was the first public recommendation made by Ami Fadia?

On 2016

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?